Innovalve Bio Medical Ltd

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Innovalve Bio Medical Ltd - overview

Established

2017

Location

Ramat Gan, -, Israel

Primary Industry

Medical Devices & Equipment

About

Based in Ramat Gan, Israel, and founded in 2017 by co-founders Dr. Ehud Raanani and Dr. Boris Orlov, Innovalve Bio Medical Ltd. , operates as a hospital and teaching center that provide physicians and patients with new non-surgical modalities for the treatment of heart valve morbidities, in particular – mitral valve regurgitation.


In August 2020, Innovalve Bio Medical Ltd. raised USD 10. 5 million in venture funding led by new investor ALIVE. As of June 2022, the company is led by its CEO Eyal Baror.


Innovalve Bio Medical Ltd. develops an artificial mitral valve that can be replaced using a minimally-invasive catheter to help treat patients suffering from heart disease. The company TMVR Innostay System is intended for use in adult patients with symptomatic moderate-severe and severe mitral regurgitation who are at elevated risk for surgical mitral valve repair or replacement and who are anatomically eligible for a transfemoral catheterization with a transseptal approach to the left atrium is comprised of two main components such as Valve Prosthesis and delivery system.


Current Investors

ALIVE, OurCrowd

Primary Industry

Medical Devices & Equipment

Sub Industries

Therapeutic Devices

Verticals

Manufacturing

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.